Metraipolis › archive › dc_014b15fe828d
Prognostic Significance of Inflammatory Biomarkers in First-Line Immunotherapy for Metastatic Melanoma: Multicentric Study — Europe PMC PMID:42279306
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42279306
- DOI
- 10.3390/cancers18111722
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T06:17:11.459Z
- SHA-256 of the archived text
4a921ffd3fe845409f576ec202e633c42c4228946c0b4dffa82135d64d434fd4- Stable URL of this page
https://metraipolis.com/documento/dc_014b15fe828d
How to cite
Prognostic Significance of Inflammatory Biomarkers in First-Line Immunotherapy for Metastatic Melanoma: Multicentric Study — Europe PMC PMID:42279306 — Europe PMC (en), https://europepmc.org/article/MED/42279306 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_014b15fe828d (Metraipolis archive dc_014b15fe828d, sha256 4a921ffd3fe845409f576ec202e633c42c4228946c0b4dffa82135d64d434fd4)
BibTeX
@misc{dc014b15fe828d,
title = {Prognostic Significance of Inflammatory Biomarkers in First-Line Immunotherapy for Metastatic Melanoma: Multicentric Study — Europe PMC PMID:42279306},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42279306},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_014b15fe828d; sha256 4a921ffd3fe845409f576ec202e633c42c4228946c0b4dffa82135d64d434fd4},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42279306. Agents can read the archived copy with the MCP tool read_document.